Literature DB >> 17274001

CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.

Nataly Manjarrez-Orduño1, Miguel E Moreno-García, Katja Fink, Leopoldo Santos-Argumedo.   

Abstract

It is becoming increasingly clear that the regulation of proliferation and differentiation of B cells to plasma cells involves the integration of a variety of intracellular signals provided by receptors of both the adaptive and innate immune system. The cross-linking of the surface molecule CD38 induces calcium mobilization, protein phosphorylation and NF-kappaB translocation into the nucleus, ultimately leading to proliferation and isotype switching toward IgG1. Here we describe (a) the effect on B cell activation of stimulating through both CD38 and Toll-like receptors 4, 7 and 9; and (b) that CD38 cross-linking increases the number of proliferating cells and the rate of proliferation in LPS-stimulated B cells by a Bruton's tyrosine kinase- and protein kinase C-dependent mechanism. In contrast, CD38 cross-linking reduces the number of cells committed to IgM plasma cell differentiation as measured by the number of CD138+ cells, antibody secretion, and the expression of PAX5, Bcl6 and Blimp-1. Since a putative ligand for CD38 is expressed by germinal center follicular dendritic cells, and CD38 expression is down-regulated in germinal center B cells, we speculate that CD38 might participate in the outcome of post-germinal center antibody responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17274001     DOI: 10.1002/eji.200636453

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Authors:  Héctor Romero-Ramírez; Monserrat Teresa Morales-Guadarrama; Rosana Pelayo; Rubén López-Santiago; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Soluble CD38 significantly prolongs the lifespan of memory B-cell responses.

Authors:  Xue Q Liu; Derek N J Hart; Gordon G MacPherson; Michael F Good; Michelle N Wykes
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

3.  Effects of the in vivo supply of butyrate on histone acetylation of cecum in piglets.

Authors:  C Lawrence Kien; Cheryl P Peltier; Soma Mandal; James R Davie; Ruth Blauwiekel
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Jan-Feb       Impact factor: 4.016

4.  The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Shoshana Levy; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

5.  Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response.

Authors:  Hannah Law; Melanie Mach; Annett Howe; Solange Obeid; Brad Milner; Cate Carey; Maxine Elfis; Bertha Fsadni; Katherine Ognenovska; Tri Giang Phan; Diane Carey; Yin Xu; Vanessa Venturi; John Zaunders; Anthony D Kelleher; C Mee Ling Munier
Journal:  iScience       Date:  2021-12-18

Review 6.  Role of B cells as antigen presenting cells.

Authors:  Ichwaku Rastogi; Donghwan Jeon; Jena E Moseman; Anusha Muralidhar; Hemanth K Potluri; Douglas G McNeel
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

7.  Combinatorial signaling through TLR-2 and CD86 augments activation and differentiation of resting B cells.

Authors:  Shweta Jain; Sathi Babu Chodisetti; Javed N Agrewala
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.

Authors:  Ilana C van Rensburg; Chandre Wagman; Kim Stanley; Caroline Beltran; Katharina Ronacher; Gerhard Walzl; Andre G Loxton
Journal:  Oncotarget       Date:  2017-01-10

Review 9.  Roles of CD38 in the Immune Response to Infection.

Authors:  Estibaliz Glaría; Annabel F Valledor
Journal:  Cells       Date:  2020-01-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.